Barrett & Company’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2K Sell
42
-1
-2% -$315 ﹤0.01% 472
2026
Q1
$13.8K Buy
43
+1
+2% +$359 ﹤0.01% 441
2025
Q4
$14.8K Hold
42
﹤0.01% 435
2025
Q3
$15.5K Hold
42
0.01% 434
2025
Q2
$16.6K Hold
42
0.01% 434
2025
Q1
$15.6K Hold
42
0.01% 402
2024
Q4
$15.1K Hold
42
0.01% 401
2024
Q3
$15.2K Hold
42
0.01% 393
2024
Q2
$14.3K Hold
42
0.01% 401
2024
Q1
$15K Hold
42
0.01% 399
2023
Q4
$12.6K Hold
42
0.01% 396
2023
Q3
$11.5K Sell
42
-15
-26% -$4.3K 0.01% 405
2023
Q2
$17.4K Hold
57
0.01% 365
2023
Q1
$16.3K Hold
57
0.01% 347
2022
Q4
$13.9K Hold
57
0.01% 353
2022
Q3
$13.9K Buy
+57
New +$12K 0.01% 353

Other funds holding SYK

Barrett & Company's SYK Position: Q2 2026 in Review

Barrett & Company reduced its Stryker (SYK) stake by 2.3% in Q2 2026, selling an estimated $315 and leaving 42 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #472.

Barrett & Company first reported a position in SYK in Q3 2022 and has held it in 16 quarters since. The position peaked at $17.4K in Q2 2023. 2,263 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Barrett & Company held 42 shares of Stryker worth $13.2K as of Q2 2026.
  • Barrett & Company sold 1 Stryker share in Q2 2026, an estimated $315.
  • Stryker made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #472 holding.
  • Barrett & Company first reported a position in Stryker in Q3 2022 and has held it in 16 quarters since.
  • Barrett & Company's Stryker position peaked at $17.4K in Q2 2023.
  • 2,263 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.